Rosuvastatin vs. Atorvastatin; Bempedoic Acid; Immediate versus staged PCI; Stroke Anticoagulation; Semaglutide in Obesity without Diabetes

Resources:

Rosuvastatin vs. Atorvastatin Treatment in Patients With Coronary Artery Disease – LODESTAR

https://www.bmj.com/content/383/bmj-2023-075837

https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/08/23/19/37/lodestar

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients – CLEAR Outcomes trial

https://www.nejm.org/doi/full/10.1056/NEJMoa2215024

https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/03/01/23/31/clear-outcomes

Immediate versus staged complete revascularization in patients presenting with acute coronary syndrome and multivessel coronary disease: a prospective, open-label, non-inferiority, randomized trial – BIOVASC

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00351-3/fulltext

https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/03/01/23/40/biovasc

Early versus Later Anticoagulation for Stroke with Atrial Fibrillation – ELAN trial

https://www.nejm.org/doi/full/10.1056/NEJMoa2303048

https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/05/24/17/31/elan

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes – SELECT trial

https://www.nejm.org/doi/full/10.1056/NEJMoa2307563

https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/11/09/15/04/select